Nucleus Expands Radiopharmaceutical Capacity to Tackle Supply Issues
Nucleus expands facilities to boost radiopharmaceutical production and ease supply chain issues.
Nucleus RadioPharma is expanding its capabilities in radiopharmaceutical research and manufacturing by establishing two new facilities in Arizona and Pennsylvania. This move is designed to tackle current nationwide supply chain constraints in the industry, improving access to critical radiopharmaceuticals used in cancer treatment and diagnostics.
The facilities will collectively span over 100,000 square feet and aim to bolster production for clinical trials and commercial distribution. Nucleus RadioPharma's partnerships with leading institutions like Mayo Clinic and Fox Chase Cancer Center are key to advancing this growth.
This expansion will create jobs and enhance regional healthcare infrastructure, addressing urgent demand for life-saving radiopharmaceuticals while supporting local economies.
My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.
Plus dans Pharma News
Tous les articles →
Curia New York reçoit une lettre d’avertissement de la FDA concernant des milliers d’injections chromatographiques non documentées
Ab Science révise les calendriers d'essais après trois inspections GCP
Discussion